Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Neuropediatrics
|
October 12, 2022
Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual
Katja Steinbrücker, Elke Tiefenthaler, Eva-Maria Schernthaner, et al.
Genes
|
December 23, 2022
A <i>TSHZ3</i> Frame-Shift Variant Causes Neurodevelopmental and Renal Disorder Consistent with Previously Described Proximal Chromosome 19q13.11 Deletion Syndrome
René G Feichtinger, Martin Preisel, Katja Steinbrücker, et al.
Immunology Letters
|
November 18, 2024
Vaccine safety in children with genetically confirmed mitochondrial disease
Annemarie de Vreugd, Franz A Zimmermann, Katja Steinbrücker, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
January 10, 2025
Mitochondrial disorder diagnosis and management- what the pediatric neurologist wants to know
Oliver Heath, René G Feichtinger, Melanie T Achleitner, et al.
Neuropediatrics
|
January 5, 2023
Treatment of Mitochondrial Phenylalanyl-tRNa-Synthetase Deficiency (FARS2) with Oral Phenylalanine
Susanne L Oswald, Katja Steinbrücker, Melanie T Achleitner, et al.
Molecular Metabolism
|
July 14, 2026
Biallelic TXNIP deficiency is associated with a multisystemic metabolic disease
Julia-Josefine Scholz, Sharlaine Y L Piel, Ioannis Evangelakos, et al.
Nutrients
|
September 9, 2022
Ketogenic Diet Treatment of Defects in the Mitochondrial Malate Aspartate Shuttle and Pyruvate Carrier
Bigna K Bölsterli, Eugen Boltshauser, Luigi Palmieri, et al.
Annals of Neurology
|
December 26, 2021
Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes
Michael Zech, Robert Kopajtich, Katja Steinbrücker, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Neuropediatrics
|
October 12, 2022
Nicotinamide Riboside for Ataxia Telangiectasia: A Report of an Early Treated Individual
Katja Steinbrücker, Elke Tiefenthaler, Eva-Maria Schernthaner, et al.
Genes
|
December 23, 2022
A <i>TSHZ3</i> Frame-Shift Variant Causes Neurodevelopmental and Renal Disorder Consistent with Previously Described Proximal Chromosome 19q13.11 Deletion Syndrome
René G Feichtinger, Martin Preisel, Katja Steinbrücker, et al.
Immunology Letters
|
November 18, 2024
Vaccine safety in children with genetically confirmed mitochondrial disease
Annemarie de Vreugd, Franz A Zimmermann, Katja Steinbrücker, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society
|
January 10, 2025
Mitochondrial disorder diagnosis and management- what the pediatric neurologist wants to know
Oliver Heath, René G Feichtinger, Melanie T Achleitner, et al.
Neuropediatrics
|
January 5, 2023
Treatment of Mitochondrial Phenylalanyl-tRNa-Synthetase Deficiency (FARS2) with Oral Phenylalanine
Susanne L Oswald, Katja Steinbrücker, Melanie T Achleitner, et al.
Molecular Metabolism
|
July 14, 2026
Biallelic TXNIP deficiency is associated with a multisystemic metabolic disease
Julia-Josefine Scholz, Sharlaine Y L Piel, Ioannis Evangelakos, et al.
Nutrients
|
September 9, 2022
Ketogenic Diet Treatment of Defects in the Mitochondrial Malate Aspartate Shuttle and Pyruvate Carrier
Bigna K Bölsterli, Eugen Boltshauser, Luigi Palmieri, et al.
Annals of Neurology
|
December 26, 2021
Variants in Mitochondrial ATP Synthase Cause Variable Neurologic Phenotypes
Michael Zech, Robert Kopajtich, Katja Steinbrücker, et al.
Page
of 1